メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
設備
プロジェクト
研究成果
受賞
活動
授業
専門知識、名前、または所属機関で検索
母性看護学講座
富山大学
医学系
概要
フィンガープリント
ネットワーク
プロファイル
(4)
プロジェクト
(9)
研究成果
(14)
受賞
(1)
活動
(14)
フィンガープリント
母性看護学講座が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Acyclovir Resistance
100%
Acyclovir
100%
Japan
64%
Herpes Simplex Virus
51%
Cytomegalovirus Infection
50%
Plaque Formation
40%
Herpes Simplex Virus 2 (HSV-2)
40%
Varicella Zoster Virus
37%
Childrens
37%
Suppressive Therapy
35%
Resistant Virus
31%
Post-infection
27%
Lung
27%
Virus Isolate
27%
Cell-free Virus
25%
Disinfection Efficiency
25%
Traditional Herbs
25%
Guanosine
25%
Varicella-zoster Virus Infection
25%
Virus Infection
25%
Neuraminidase
25%
Cross-resistance
25%
Glycoprotein
25%
Inhibitory Action
25%
Prophylactic Treatment
25%
Penciclovir
25%
Exclusive Breastfeeding
25%
Natural Killer Cell Activity
25%
Adjusted Odds Ratio
25%
FK506
25%
Geum Japonicum
18%
Murine CMV
18%
Virus Yield
18%
Cyclosporine
15%
Infected Mice
14%
Virus
14%
Viral
14%
CMV Infection
12%
Anti-cytomegalovirus Activity
12%
Viral Glycoprotein
12%
Inhibitory Activity
12%
Activity in Vivo
12%
Syzygium Aromaticum
12%
Terminalia Chebula
12%
Monoclonal Antibody
12%
Human Cytomegalovirus
12%
Miscarriage
12%
Quality of Life
12%
Pregnant Women
12%
Stillbirth
12%
Antibody Production
11%
Immunosuppression
11%
Genital Lesions
10%
Genital Herpes
10%
Plaque-forming Units
10%
Confidence Interval
8%
Early Pregnancy
8%
Nave
8%
Resistant Clones
8%
History of Miscarriage
7%
Late Pregnancy
7%
Episodic Treatment
6%
Rhus Javanica
6%
Virus Population
6%
Cytomegalovirus Disease
6%
Production Yield
6%
Early Skin-to-skin Contact
6%
Exclusively Breastfed
6%
Rooming-in
6%
Oral Treatment
6%
Water Treatment
6%
Hot Water Extract
6%
Immunocompromised Patients
6%
Intraperitoneal Infection
6%
Herpes Simplex Virus Type 1 (HSV-1)
6%
In Vitro Activity
6%
Immunodeficient Mice
6%
Ganciclovir
6%
Virus Activity
6%
Orally Administered
6%
Intraperitoneal Administration
6%
Anti-herpes Simplex Virus
6%
Herbal Extracts
6%
Plaque
6%
Breastfeeding Initiation
6%
Infection Model
6%
During Pregnancy
5%
Thymidine Kinase
5%
Immunology and Microbiology
Herpes Simplex Virus 2
66%
Herpes Simplex Virus
62%
Varicella Zoster Virus
50%
Genital Herpes
45%
Plaque-Forming Unit
41%
Human Alphaherpesvirus 1
25%
Glycoprotein
25%
Viral Disease
25%
Cross-Resistance
25%
Cytomegalovirus Infection
25%
Tacrolimus
25%
Low Drug Dose
25%
Natural Killer Cell
25%
Third Trimester Pregnancy
12%
Defective Interfering Particle
12%
Virus Type
12%
Effective Concentration
10%
DNA Polymerase
10%
First Trimester Pregnancy
9%
IC50
8%
Viral Entry
8%
Monoclonal Antibody
8%
Antibody Production
5%
Immunosuppression
5%
Virus Resistance
5%
EC50
5%
Antiviral Activity
5%
Virus Strain
5%
DNA Virus
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aciclovir
50%
Varicella Zoster Virus
37%
Herpes Simplex Virus
31%
Infection
27%
Sialidase
25%
Guanosine
25%
Penciclovir
25%
Cross-Resistance
25%
Herpes Zoster
25%
Virus Infection
25%
Glycoprotein
25%
Cytomegalovirus Infection
25%
Geum
18%
Virus Glycoprotein
12%
Monoclonal Antibody
12%
Cytomegalovirus
12%
Terminalia chebula
12%
Clove
12%
Ciclosporin
12%
Rhus
6%
Human Cytomegalovirus
6%
Murine Cytomegalovirus
6%
Ganciclovir
6%
Hot Water
6%
Peritonitis
6%
Immunocompromised Patient
6%